Scholarlink

Background <p>Ischemic heart disease (IHD) continues to rank among the leading global causes of mortality, consistently linked to long-term exposure to fine particulate matter (PM<sub>2.5</sub>). Despite a declining trend in the annual average PM<sub>2.5</sub> concentration in Seoul, they still fail to meet the air quality standards set by the Korean Ministry of Environment (15&#xa0;µg/m<sup>3</sup>). We aim to estimate the IHD mortality attributable to PM<sub>2.5</sub> and the health benefits derived from reducing PM<sub>2.5</sub> concentration in Seoul, South Korea, between 2016 and 2020.</p> Methods <p>We utilized machine-learning-based PM<sub>2.5</sub> data, Global Exposure Mortality Model, mortality data, and population data to estimate the burden of IHD mortality attributed to PM<sub>2.5</sub> and the benefits in IHD mortality associated with reductions in PM<sub>2.5</sub> concentration in Seoul between 2016 and 2020. We also estimated the health benefits by considering the reference concentration in three reduction scenarios.</p> Results <p>During the study period, the average PM<sub>2.5</sub> concentration was 23.5&#xa0;µg/m<sup>3</sup>, with 10,971 IHD deaths among individuals aged ≥ 25 years. We estimated 2,861 excess IHD deaths (aged ≥ 25 years) attributable to PM<sub>2.5</sub> exposure between 2016 and 2020. Under the PM<sub>2.5</sub> reduction scenario, achieving a PM<sub>2.5</sub> concentration of 15&#xa0;µg/m<sup>3</sup> corresponds to an avoidable mortality rate of approximately 8%.</p> Conclusions <p>Our study assessed the burden of IHD mortality attributable to ambient PM<sub>2.5</sub> and the potential health benefits associated with its reduction in Seoul between 2016 and 2020. The findings suggest that continued efforts to reduce PM<sub>2.5</sub> concentrations could significantly mitigate IHD mortality, particularly in the context of an aging population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ischemic heart disease mortality due to fine particulate matter in Seoul between 2016 and 2020

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月22日

查看全文
  • Jongmin Oh,
  • Myung-Sook Park,
  • Yun-Chul Hong,
  • Ho Kim,
  • Whanhee Lee,
  • Ejin Kim,
  • Cinoo Kang,
  • Insung Song,
  • Hyemin Jang,
  • Jieun Min,
  • Dohoon Kwon,
  • Jieun Oh,
  • Jeongmin Moon,
  • Jinah Park,
  • Ayoung Kim,
  • Seoyeong Ahn

摘要

Background

Ischemic heart disease (IHD) continues to rank among the leading global causes of mortality, consistently linked to long-term exposure to fine particulate matter (PM2.5). Despite a declining trend in the annual average PM2.5 concentration in Seoul, they still fail to meet the air quality standards set by the Korean Ministry of Environment (15 µg/m3). We aim to estimate the IHD mortality attributable to PM2.5 and the health benefits derived from reducing PM2.5 concentration in Seoul, South Korea, between 2016 and 2020.

Methods

We utilized machine-learning-based PM2.5 data, Global Exposure Mortality Model, mortality data, and population data to estimate the burden of IHD mortality attributed to PM2.5 and the benefits in IHD mortality associated with reductions in PM2.5 concentration in Seoul between 2016 and 2020. We also estimated the health benefits by considering the reference concentration in three reduction scenarios.

Results

During the study period, the average PM2.5 concentration was 23.5 µg/m3, with 10,971 IHD deaths among individuals aged ≥ 25 years. We estimated 2,861 excess IHD deaths (aged ≥ 25 years) attributable to PM2.5 exposure between 2016 and 2020. Under the PM2.5 reduction scenario, achieving a PM2.5 concentration of 15 µg/m3 corresponds to an avoidable mortality rate of approximately 8%.

Conclusions

Our study assessed the burden of IHD mortality attributable to ambient PM2.5 and the potential health benefits associated with its reduction in Seoul between 2016 and 2020. The findings suggest that continued efforts to reduce PM2.5 concentrations could significantly mitigate IHD mortality, particularly in the context of an aging population.